Open access
Impact of post‐chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children’s Oncology Group AREN0532, AREN0533, and AREN03B2 studies
N. Evageliou
L. Renfro
K. Vallance
Carly R. Varela
D. Benedetti
Nicholas G. Cost
Peter F. Ehrlich
John A. Kalapurakal
G. Khanna
J. Aldrink
R. Glick
M. Ortiz
Lauren N. Parsons
A. Paulino
Maddy Artunduaga
Ethan A. Smith
David B. Dix
Conrad V. Fernandez
J. Dome
James I. Geller
E. Mullen
Medicine
Abstract
Improvements in therapy for patients with favorable histology Wilms tumor (FHWT) have relied on refinement of risk stratification for therapeutic assignment through identification of favorable and unfavorable prognostic factors. Although well established in International Society of Pediatric Oncology‐Renal Tumor Study Group protocols, the Children’s Oncology Group (COG) has not historically used post‐chemotherapy histology (PCH) to guide therapy. This study examines whether outcomes are associated with PCH classification in the COG treatment context.